Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

31,147 trials

NCT07263022
Recruiting
Cognitive Strategies in Early Psychosis 2
Phase 3 · United States · 1 site
Registry update: 23 Jul 2026
NCT07654374
Recruiting
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Phase 3 · United States · 70 sites
Registry update: 20 Oct 2026
NCT07710729
Recruiting
A Research Study Looking Into How UBT251 Works With Birth Control Tablets and Emptying of the Stomach in Women With Excess Body Weight Not Able to Become Pregnant
Phase 1 · Canada · 1 site
Registry update: 25 Aug 2026
NCT07591090
Recruiting
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer
Phase 2 · China · 1 site
Registry update: 22 Jul 2026
NCT07725562
Recruiting
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
Phase 2/3 · China · 1 site
Registry update: 3 Sept 2026
2025-523127-21-00
Recruiting
A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
Phase 1 · Belgium, Germany, Spain, Italy, Netherlands · 13 sites
Registry update: 1 Sept 2026
NCT07657312
Recruiting
Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma
Phase 2 · United States · 1 site
Registry update: 6 Oct 2026
NCT07606950
Recruiting
Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Phase 3 · China · 1 site
Registry update: 24 Jul 2026
2025-522076-85-00
Recruiting
A study to investigate how well and safe a trial drug called AZD1163, administered as an injection, works in improving symptoms and inflammation in adult participants with moderately to severely active rheumatoid arthritis.
Phase 2 · Bulgaria, Germany, Spain, Hungary, Poland · 30 sites
Registry update: 7 Oct 2026
NCT07674628
Recruiting
SALUD-M: Acceptance Based Coping Skills for Hispanic/Latinx Military Patients With Type 2 Diabetes
Not applicable · United States · 1 site
Registry update: 28 Jul 2026
NCT07699029
Recruiting
Endovascular Treatment for Posterior Circulation Ischemic Stroke Post 1 Day （24 Hours）
Not applicable · China · 1 site
Registry update: 30 Jul 2026
NCT07569198
Recruiting
Ketamine With Dialectical Behavioural Therapy (DBT) for Suicidality in Individuals With Treatment-Resistant Depression and Borderline Personality Disorder (KET-DBT)
Phase 2 · Canada · 1 site
Registry update: 29 Jul 2026
NCT07406035
Recruiting
A Clinical Trial of TQH3906 Capsules in the Treatment of Active Psoriatic Arthritis
Phase 2 · China · 43 sites
Registry update: 2 Sept 2026
NCT07452458
Recruiting
Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma
Phase 3 · United States · 54 sites
Registry update: 10 Sept 2026
NCT07640295
Recruiting
Study of JAB-23E73 in Combination With Chemotherapy in Participants With Metastatic PDAC Harboring KRAS Gene Alterations
Phase 1/2 · China · 13 sites
Registry update: 27 Aug 2026
NCT07636785
Recruiting
A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
Phase 1/2 · United States · 2 sites
Registry update: 3 Nov 2026
NCT07532265
Recruiting
A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
Phase 2 · Bulgaria, Czechia, Germany, Greece, Hungary, Poland, Romania, United States · 58 sites
Registry update: 28 Jul 2026
NCT07693426
Recruiting
Phase Ib Study of Efsubaglutide Alfa Injection in Obese Adolescents
Phase 1 · China · 5 sites
Registry update: 30 Jul 2026
NCT07088458
Recruiting
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
Not applicable · Brazil, Canada, Colombia, Denmark, Spain, Italy, Japan, Lithuania, Mexico, Norway, United States · 12 sites
Registry update: 26 Oct 2026
NCT07720284
Recruiting
An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
Phase 3 · Australia, Brazil, Canada, China, Germany, Spain, France, United Kingdom, India, Italy, Japan, South Korea, Poland, Thailand, Taiwan, United States · 136 sites
Registry update: 22 Jul 2026

Ordered by registry start date. Freshness and sponsorship never change the order.